| TAZPOWER Patients (n = 12) |  | Natural History Controls (n = 12) |  |
---|---|---|---|---|
Slope Model Analysis | Â | Â | Â | Â |
 | LV stroke volume (mL) |  |  |  |
 |  | Mean (SD) change from baseline; range | 3.44 (5.26); − 1.7, 18.3 |  − 0.26 (2.66); − 4.9, 3.7 |
 |  | P value | 0.0407 |  |
 | LV end-diastolic volume (mL) |  |  |  |
 |  | Mean (SD) change from baseline; range | 4.89 (7.25); − 1.5, 24.7 | 0.91 (6.15); − 12.3, 11.2 |
 |  | P value | 0.1609 |  |
 | LV end-systolic volume (mL) |  |  |  |
 |  | Mean (SD) change from baseline; range | 1.46 (2.26); − 2.0, 6.4 | 1.17 (4.29); − 7.4, 9.1 |
 |  | P value | 0.8417 |  |
Mixed Model Analysis | Â | Â | Â | Â |
 | LV stroke volume (mL) |  |  |  |
 |  | LS mean change from baseline | 1.92 − 4.80 |  |
 |  | LS mean difference (95% CI), P value | 6.72 (2.75, 10.69); P = 0.0020 |  |
 | LV end-diastolic volume (mL) |  |  |  |
 |  | LS mean change from baseline | 2.08 − 2.66 |  |
 |  | LS mean difference (95% CI), P value | 4.75 (− 2.72, 12.22); P = 0.2006 |  |
 | LV end-systolic volume (mL) |  |  |  |
 |  | LS mean change from baseline | 0.52 1.28 |  |
 |  | LS mean difference (95% CI), P value |  − 0.77 (− 7.13, 5.60); P = 0.8047 |  |